Drug Type Degradable Molecular Glue |
Synonyms- |
Target |
Action inhibitors |
Mechanism HDAC3 inhibitors(Histone deacetylase 3 inhibitors), SIAH2 inhibitors(siah E3 ubiquitin protein ligase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 09 Apr 2024 | |
Neoplasms | Preclinical | China | 09 Apr 2024 |